Comparison of trinitroglycerin and adenosine as provocative agents for head-up tilt test in patients with unexplained syncope: a semi-crossover randomized clinical trial with prospective follow-up

[1]  Oral Communications , 2009, 2022 21st International Symposium on Parallel and Distributed Computing (ISPDC).

[2]  S. Abbasi,et al.  The Tehran Heart Center. , 2018, European heart journal.

[3]  P. Mitro,et al.  Gene Polymorphism of the Adenosine A2a Receptor in Patients with Vasovagal Syncope , 2016, Pacing and clinical electrophysiology : PACE.

[4]  J. Deharo,et al.  Adenosine and Clinical Forms of Neurally-Mediated Syncope. , 2015, Journal of the American College of Cardiology.

[5]  C. Pappone,et al.  The use of adenosine and adenosine triphosphate testing in the diagnosis, risk stratification and management of patients with syncope: current evidence and future perspectives. , 2015, International journal of cardiology.

[6]  M. Kawamura,et al.  Characteristics of head‐up tilt testing with additional adenosine compared with head‐up tilt testing with isoproterenol and isosorbide dinitrate , 2014 .

[7]  C. Berry,et al.  Adenosine: physiology, pharmacology, and clinical applications. , 2014, JACC. Cardiovascular interventions.

[8]  C. Forleo,et al.  Head-up tilt testing for diagnosing vasovagal syncope: a meta-analysis. , 2013, International journal of cardiology.

[9]  J. Deharo,et al.  Syncope without prodromes in patients with normal heart and normal electrocardiogram: a distinct entity. , 2013, Journal of the American College of Cardiology.

[10]  J. Deharo,et al.  A2A adenosine receptor function in patients with vasovagal syncope. , 2013, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[11]  J. Deharo,et al.  Adenosine plasma level and A2A adenosine receptor expression: correlation with laboratory tests in patients with neurally mediated syncope , 2012, Heart.

[12]  I. Holme,et al.  Risk factors for unexpected sudden death in patients with non-symptomatic aortic stenosis (the SEAS study) , 2010 .

[13]  R. Faria,et al.  Positioning of the egc leads in Brugada Syndrome: higher sensitivy with lower specificity? Answers from a genetically characterized family , 2009 .

[14]  S. Lévy,et al.  Head-up tilt induced syncope and adenosine A2A receptor gene polymorphism. , 2009, European heart journal.

[15]  S. Lévy,et al.  Increased expression of adenosine A2A receptors in patients with spontaneous and head-up-tilt-induced syncope. , 2006, Heart rhythm.

[16]  P. Mitro,et al.  Diagnostic yield of adenosine and nitroglycerine stimulated tilt test in patients with unexplained syncope. , 2007, Bratislavske lekarske listy.

[17]  A. N. Sulke,et al.  A randomised prospective comparison of three protocols for head-up tilt testing and carotid sinus massage. , 2005, International journal of cardiology.

[18]  S. Markowitz,et al.  Single‐Stage Adenosine Tilt Testing in Patients with Unexplained Syncope , 2004, Journal of cardiovascular electrophysiology.

[19]  S. Lévy,et al.  Role of Endogenous Adenosine as a Modulator of Syncope Induced During Tilt Testing , 2002, Circulation.

[20]  S. Markowitz,et al.  Clinical utility of an adenosine-nitroglycerin tilt test protocol , 2002 .

[21]  M. Brignole,et al.  Clinical features of adenosine sensitive syncope and tilt induced vasovagal syncope , 2000, Heart.

[22]  W. Shen,et al.  Vasovagal syncope. , 2000, Annals of internal medicine.

[23]  W. Shen,et al.  Vasovagal Syncope , 2000, Annals of Internal Medicine.

[24]  M. Brignole,et al.  New classification of haemodynamics of vasovagal syncope: beyond the VASIS classification. Analysis of the pre-syncopal phase of the tilt test without and with nitroglycerin challenge. Vasovagal Syncope International Study. , 2000, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[25]  S. Markowitz,et al.  Induction of neurally mediated syncope with adenosine. , 1999, Circulation.

[26]  J. Shryock,et al.  Adenosine and adenosine receptors in the cardiovascular system: biochemistry, physiology, and pharmacology. , 1997, The American journal of cardiology.

[27]  K. Bailey,et al.  Adenosine: potential modulator for vasovagal syncope. , 1996, Journal of the American College of Cardiology.

[28]  S. Su,et al.  Excessive myocardial contraction in vasovagal syncope demonstrated by echocardiography during head‐up tilt test , 1996, Clinical cardiology.

[29]  T. Iwamoto,et al.  Identification of adenosine A2 receptor-cAMP system in human aortic endothelial cells. , 1994, Biochemical and biophysical research communications.

[30]  M Akhtar,et al.  Echocardiographic demonstration of decreased left ventricular dimensions and vigorous myocardial contraction during syncope induced by head-up tilt. , 1991, Journal of the American College of Cardiology.

[31]  T. J. Killian,et al.  Adenosine Increases Sympathetic Nerve Traffic in Humans , 1991, Circulation.

[32]  L. Arroyo,et al.  2-Alkoxyadenosines: potent and selective agonists at the coronary artery A2 adenosine receptor. , 1991, Journal of medicinal chemistry.

[33]  I. Biaggioni,et al.  Cardiovascular and Respiratory Effects of Adenosine in Conscious Man: Evidence for Chemoreceptor Activation , 1987, Circulation research.

[34]  E. Jackson.  Role of adenosine in noradrenergic neurotransmission in spontaneously hypertensive rats. , 1987, The American journal of physiology.

[35]  R. Berne,et al.  Release of Adenosine from Ischemic Brain: Effect on Cerebral Vascular Resistance and Incorporation into Cerebral Adenine Nucleotides , 1974 .